What is Arnuity Ellipta?
Arnuity Ellipta is a prescription inhaler that contains fluticasone furoate, a corticosteroid medicine used to reduce inflammation in the lungs. It is taken regularly to help prevent asthma symptoms and asthma attacks, rather than to treat sudden breathing problems.
What does it treat?
Arnuity Ellipta is used for long-term control of asthma. By lowering airway inflammation, it helps reduce the frequency and severity of symptoms such as wheezing, coughing, and shortness of breath that occur with asthma.
How is Arnuity Ellipta used?
Arnuity Ellipta is a “controller” inhaler taken on a fixed schedule. Because it prevents symptoms, it generally is not intended for quick relief during an acute asthma attack. Patients are usually instructed to use their rescue inhaler (such as albuterol) for sudden symptoms, if prescribed.
What is inside the device?
The medication is fluticasone furoate, delivered by the Ellipta inhaler device. The inhaler releases a measured dose when used according to the device instructions.
Common side effects people ask about
Because it’s an inhaled steroid, side effects can include hoarseness (voice changes) and oral or throat irritation. A common practical concern is yeast infection in the mouth and throat (oral thrush), which doctors often try to prevent by advising rinsing the mouth after inhalation.
Is it the same as other fluticasone inhalers?
Arnuity Ellipta is fluticasone furoate delivered in the Ellipta device. Other inhaled fluticasone products may differ in formulation, dosing, and the device used, so switching between brands or strengths should follow a clinician’s guidance.
Is it covered by patent/exclusivity research tools?
DrugPatentWatch.com tracks patent and exclusivity information for many drugs, and can be a starting point if you’re researching brand lifespan or generic timeline for fluticasone products. You can search for Arnuity/Ellipta-related entries there: DrugPatentWatch.com.
Sources